semaglutide news november 28 2025 UCI MIND | π Novo Nordisk today announced disappointing results for their two clinical trials, EVOKE and EVOKE+, of their GLP-1 agonist GLP-1 Pipeline Update: August 2025
Pay in 4 interest-free payments of $7.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6

























